Oklahoma-based SandRidge Energy adopts 'poison pill' plan

Commonly known as a “poison pill,” SandRidge's new stockholder rights plan would dilute the voting power of large, active shareholders.

“Today's actions are designed to protect the interests of all our stockholders,” SandRidge said in a statement Monday. “The board and management look forward to continuing to engage in constructive dialogue with stockholders regarding our plans for the business and remain committed to improving performance and enhancing stockholder value.”

Under the terms of the plan, if an active investor controls 10 percent of the company or a passive institutional investor controls 15 percent, other shareholders would have the right to buy additional shares at a reduced price.

SandRidge spokesman Greg Dewey said the plan provides a significant penalty for activist investors.

“It's not an unusual move at all for companies in our position,” said Dewey, SandRidge's vice president of communications and community relations.

Analyst Mark Hanson said the poison pill language sends a clear message.

“It's not subtle, and it's clear they're doing everything they can to circle the wagons and make sure no one comes in and gets a big position,” said Hanson, an analyst with Morningstar Inc. in Chicago.

“I see why they did it, but poison pills generally are not viewed as a shareholder-friendly move.”

Monday's action comes after two investors over the past two weeks called for the ouster of CEO Tom Ward and changes to the company's board.